← Leaderboards
Brian Penny
Albany Molecular Research, Inc.
$907,791
Attributed
$907,791
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $545.1K · FY2023–25$1M$750K$500K$250K$0
'23
'24
'25
Funding mix
By agency
NIH$907,791 · 1
By mechanism
N01$907,791 · 1
Top collaborators
No co-investigators on record.
Most similar at Albany Molecular Research, Inc.
Same institution · by research overlap
- Keith Barnes$45,425,605
- Melissa Allard$16,991,646
- John Reilly$2,579,604
- Carrie Costello$1,542,434
- Greg Martin$1,915,086
Others in their field
Other Rising Stars on “Technology Transfer”
- Cyrus Wadia · Activate Global, Inc.$24,000,000
- Kayla Meisner · Kentucky Science & Technology Corporation$8,262,388
- Li Liang · University Of California-Irvine$7,511,446
- Agustin G Yip · Albert Einstein College Of Medicine$6,090,308
- Lauren Carter · University Of Washington$5,637,003
- Petros A Kotidis · Logistics Management Institute$4,387,731
Research focus
Technology TransferChemistryClinical TrialsContractorCyclic GmpEvaluationManufactureNational Center For Advancing Translational SciencesPreclinical SafetyQualifyingAnalytical MethodReference StandardsReportingRouteSchemeRare Diseases
Grant awards (3)
CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL$82,604
N01 · FY2025 · DA · contact PI
CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL$280,124
N01 · FY2024 · DA · contact PI
CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DEVELOPMENT OF NCGC00413972 FOR PRECLINICAL SAFETY EVALUATION AND CLINICAL TRIAL$545,063
N01 · FY2023 · DA · contact PI